Metabolic Technologies Promotes Vitamin D3, HMB Combination for Sports Market
Metabolic Technologies has launched a new website for its MyoeDge product, a combination of vitamin D3 and calcium beta-hydroxy-beta-methylbutyrate (HMB).
Photo © iStockphoto.com/mediaphotos
Metabolic Technologies, Inc. (MTI; Ames, IA) has debuted a new website for its MyoeDge formula, a combination of vitamin D3 and calcium beta-hydroxy-beta-methylbutyrate (HMB) that it is promoting on the sports-nutrition market. The newly launched site includes ingredient details, research data, and licensing information for MyoeDge.
MTI explains that while HMB supplementation has been relatively well-researched for offering improvements to lean muscle mass, strength gains, and recovery combined with intense training, the benefits of combining it with vitamin D3 have only become apparent recently. The new website is designed to explain the benefits of the combination.
For instance, results of a 2016 prospective study published on the site suggests elderly women who supplemented with HMB, protein, and vitamin D3 experienced significant increases in strength while recovering from orthopedic surgery for hip fracture.
“The goal of the MyoeDge website is to provide vital information to consumers regarding the ingredients comprising MyoeDge and the science behind those ingredients,” MTI explained, in the website announcement. “Consumers can then make an informed decision about their nutritional supplement regimen.”
The website can be found here: www.myoedge.com.
Read more:
Latest Sports-Nutrition Product Trends
Sports-Nutrition Formulators Eye Opportunities, Challenges of Plant Proteins
More Than 50 Companies Already in CRN’s Supplement OWL Database
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
References:
- Ekinci O et al., “Effect of calcium beta-hydroxy-beta-methylbutyrate (CaHMB), vitamin D, and protein supplementation on postoperative immobilization in malnourished older adult patients with hip fracture: a randomized controlled study,” Nutrition in Clinical Practice, vol. 31, no. 6 (March 2016): 829–835
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
